Home
  2014.04.24.Thurs.
E-Journal
Online Submissions
Feed Back
Papers With
a High
Impact Factor
Links
Visiting Times:
    
Visiting Times
  of Today:
      
 Now Online:
      
 
New IF of World Journal of Gastroenterology for 2009 is 2.092.
 HTML      PDF

Sari I, Birlik M, Gonen C, Akar S, Gurel D, Onen F, Akkoc N.Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment.
World J Gastroenterol 2008 May;14(18):2912-2914

Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment

Sari I, Birlik M, Gonen C, Akar S, Gurel D, Onen F, Akkoc N.

Dokuz Eylul Universitesi Tip Fakultesi Ic hastaliklari ABD Immunoloji-Romatoloji BD 35340 Inciralti, Izmir 35340, Turkey. nurullah.akkoc@deu.edu.tr

Anti-tumor necrosis factor alpha (TNF-alpha) inhibitors are effective in the treatment of various inflammatory rheumatic conditions. Increased risks of serious infections are the major issues concerning the long-term safety of these agents. We present a case of a young male Behcet's patient whose disease was complicated by cytomegalovirus (CMV) colitis. Colitis started 10 d after the third Infliximab dose and responded to the cessation of TNF blocking treatment and administration of ganciclovir. Tumor necrosis factor alpha and interferon gamma act at several levels in combating viral infections. CMV infections should be kept in mind and included in the differential diagnosis of severe gastrointestinal symptoms in patients receiving anti-TNF agents.
 


Baishideng Publishing Group Co., Limited, Flat C, 23/F., Lucky Plaza,
315-321 Lockhart Road, Wan Chai, Hong Kong, China
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.